Literature DB >> 21556962

[Current therapy of non-melanoma skin cancer].

M Schlaak1, W von Bartenwerffer, C Mauch.   

Abstract

Basal cell carcinoma, actinic keratosis as a carcinoma in situ and squamous cell carcinoma are classified as non-melanoma epithelial skin cancers. These forms of skin cancer are thought to be the most common cancers worldwide with rising incidences. In the past years new insights into the pathogenesis of non-melanoma skin cancers have been gained. Through knowledge of the pathologic pathways, new treatment options have become available. This review summarizes the recent advantages of treatment options of non-melanoma skin cancer.

Entities:  

Mesh:

Year:  2011        PMID: 21556962     DOI: 10.1007/s00105-010-2044-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  39 in total

1.  Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies.

Authors:  John Geisse; Ivor Caro; Jane Lindholm; Loren Golitz; Patti Stampone; Mary Owens
Journal:  J Am Acad Dermatol       Date:  2004-05       Impact factor: 11.527

Review 2.  Skin cancer and immunosuppression.

Authors:  Gianni Gerlini; Paolo Romagnoli; Nicola Pimpinelli
Journal:  Crit Rev Oncol Hematol       Date:  2005-10       Impact factor: 6.312

3.  Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609.

Authors:  S J Gibson; L M Imbertson; T L Wagner; T L Testerman; M J Reiter; R L Miller; M A Tomai
Journal:  J Interferon Cytokine Res       Date:  1995-06       Impact factor: 2.607

4.  HER2 and EGFR expression in cutaneous spindle squamous cell carcinoma.

Authors:  Scott M Schlauder; Kenneth B Calder; Patricia Moody; Michael B Morgan
Journal:  Am J Dermatopathol       Date:  2007-12       Impact factor: 1.533

5.  Combination of an EGFR blocker and a COX-2 inhibitor for the treatment of advanced cutaneous squamous cell carcinoma.

Authors:  Ahmad Jalili; Alice Pinc; Friederike Pieczkowski; Franz M Karlhofer; Georg Stingl; Stephan N Wagner
Journal:  J Dtsch Dermatol Ges       Date:  2008-12       Impact factor: 5.584

6.  Treatment of recurrent squamous cell carcinoma of the skin with cetuximab.

Authors:  Julie E Bauman; Keith D Eaton; Renato G Martins
Journal:  Arch Dermatol       Date:  2007-07

7.  Mutations affecting segment number and polarity in Drosophila.

Authors:  C Nüsslein-Volhard; E Wieschaus
Journal:  Nature       Date:  1980-10-30       Impact factor: 49.962

8.  Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.

Authors:  Craig A Elmets; Jaye L Viner; Alice P Pentland; Wendy Cantrell; Hui-Yi Lin; Howard Bailey; Sewon Kang; Kenneth G Linden; Michael Heffernan; Madeleine Duvic; Ellen Richmond; Boni E Elewski; Asad Umar; Walter Bell; Gary B Gordon
Journal:  J Natl Cancer Inst       Date:  2010-11-29       Impact factor: 13.506

9.  High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patients.

Authors:  M Reuschenbach; T Tran; F Faulstich; W Hartschuh; S Vinokurova; M Kloor; E Krautkrämer; M Zeier; M von Knebel Doeberitz; C Sommerer
Journal:  Br J Cancer       Date:  2011-03-22       Impact factor: 7.640

10.  Nonsurgical treatment options for Basal cell carcinoma.

Authors:  Mary H Lien; Vernon K Sondak
Journal:  J Skin Cancer       Date:  2011-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.